This Government Contract opportunity from Department Of Health And Human Services was posted on May 4, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Notice of Intent to Sole Source – Illumina
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institutes of Health (NIH) intends to award a firm fixed-price purchase order directly to Illumina, Inc. for the procurement of the Illumina MiSeq i100 System to be used at the NIH Department of Transfusion Medicine. This purchase will be conducted as a sole-source award because the equipment must be procured from the original manufacturer, Illumina, Inc., which also provides its servicing, ensuring compliance with the government's interest. The acquisition is governed by the Simplified Acquisition Procedures under Federal Acquisition Regulation (FAR) Part 13, allowing the NIH to bypass competitive solicitation due to the unique nature of the requirement and the contract’s value being below the simplified acquisition threshold. The notice clarifies that this is not a request for quotations nor will a solicitation be issued, but interested parties may express their interest and capabilities by May 14, 2026. However, the NIH reserves the right to proceed without competition based on the responses received. Questions or comments regarding this notice can be directed to Gregory Noland, the contract specialist at NIH, via email. This procurement serves the specific needs of the NIH’s Office within the Department of Health and Human Services, with performance taking place in Bethesda, Maryland.
General Info
Agency
NAICS
Place of Performance
MD, 20892, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
The National Institutes of Health (NIH) intends to award afixed price purchase order to Illumina, Inc., located at 5200 Illumina Way, San Diego, CA 92122, on a firm fixed price sole source award basis to provide the Illumina MiSeq i100 System at the National Institutes of Health, Department of Transfusion Medicine (DTM).
The instrument is manufactured and serviced by the vendor. The equipment is required by the original manufacturer (Illumina, Inc.) and it is therefore deemed to be in the Government’s best interest that this item is procured from the manufactuer.
This acquisition is being conducted using policies unique tothe Federal Acquisition Regulation (FAR) Part 13 – SimplifiedAcquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold(SAT), contracting officers may solicit from one source if thecontracting officer determines that the circumstance of thecontract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified AcquisitionProcedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Interested parties may identify their interest and capabili-ties in response to this posting. The determination by the Government not to compete the proposed requirementbased upon responses to this notice is solely within the discretion of the Government.
Comments to this announcement, referencing this postingnumber, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing datespecified in this announcement, to the attention of Gregory Noland, Contract Specialist via email to gregory.noland@nih.gov by May 14, 2026 at 10 A.M. EST.